Survival analysis suggested that low NRP1 expression in adrenocortical carcinoma (ACC), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), low-grade glioma (LGG), and stomach adenocarcinoma (STAD) was associated with poor patient prognosis. This evidence concerns the gene NRP1 and central nervous system cancer.